DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on November 8, 2007; DOI: 10.1124/dmd.107.016907


0090-9556/08/3602-217-222$20.00
DMD 36:217-222, 2008

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.107.016907v1
36/2/217    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Le Vee, M.
Right arrow Articles by Fardel, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Le Vee, M.
Right arrow Articles by Fardel, O.
SHORT COMMUNICATION

Down-Regulation of Organic Anion Transporter Expression in Human Hepatocytes Exposed to the Proinflammatory Cytokine Interleukin 1β

Marc Le Vee, Philippe Gripon, Bruno Stieger, and Olivier Fardel

Institut National de la Santé et de la Recherche Médicale U620, Faculty of Pharmacy, Rennes, France (M.L.V., O.F.); Institut National de la Santé et de la Recherche Médicale U522, Hôpital Pontchaillou, Rennes, France (P.G.); Division of Clinical Pharmacology and Toxicology, Department of Medicine, University Hospital, Zurich, Switzerland (B.S.); and Department HITC, CHU Rennes, Rennes, France (O.F.)

Interleukin (IL) 1β is a proinflammatory cytokine known to markedly alter expression of major organic anion transporters in rodent hepatocytes. However, its effects toward human hepatic transporters remain poorly characterized. Therefore, the present study was aimed at determining IL-1β effects on expression of organic anion transporters in primary human hepatocytes and highly differentiated human hepatoma HepaRG cells. Exposure to 1 ng/ml IL-1β was first shown to markedly repress mRNA expression of sodium-taurocholate cotransporting polypeptide (NTCP), a major sinusoidal transporter handling bile acids, in both human hepatocytes and HepaRG cells. It concomitantly reduced NTCP protein levels and NTCP-mediated cellular uptake of taurocholate in HepaRG cells. Other transporters such as the influx transporters organic anion transporting polypeptide (OATP)-B, OATP-C, and OATP8 and the efflux pumps multidrug resistance-associated protein (MRP) 2, MRP3, MRP4, and breast cancer resistance protein were also down-regulated at mRNA levels in human hepatocytes treated by IL-1β for 24 h, and most of these transporters were similarly repressed in IL-1β-exposed HepaRG cells; the cytokine also reduced bile salt export pump (BSEP) and OATP-C protein expression in human hepatocytes. IL-1β was further shown to activate the extracellular signal-regulated protein kinase (ERK) in human hepatocytes and HepaRG cells; however, chemical inhibition of this kinase failed to counteract repressing effects of IL-1β toward NTCP, BSEP, OATP-B, and OATP-C. Taken together, these data indicate that IL-1β treatment reduced expression of major organic anion transporters in human hepatic cells in an ERK-independent manner. Such IL-1β effects may likely participate in both cholestasis and alterations of hepatic detoxification pathways caused by inflammation in humans.


Address correspondence to: Olivier Fardel, INSERM U620, Faculté de Pharmacie, 2 avenue du Pr. Léon Bernard, 35043 Rennes, France. E-mail: olivier.fardel{at}univ-rennes1.fr




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
M. L. Vee, V. Lecureur, B. Stieger, and O. Fardel
Regulation of Drug Transporter Expression in Human Hepatocytes Exposed to the Proinflammatory Cytokines Tumor Necrosis Factor-{alpha} or Interleukin-6
Drug Metab. Dispos., March 1, 2009; 37(3): 685 - 693.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
K. Nakai, H. Tanaka, K. Hanada, H. Ogata, F. Suzuki, H. Kumada, A. Miyajima, S. Ishida, M. Sunouchi, W. Habano, et al.
Decreased Expression of Cytochromes P450 1A2, 2E1, and 3A4 and Drug Transporters Na+-Taurocholate-Cotransporting Polypeptide, Organic Cation Transporter 1, and Organic Anion-Transporting Peptide-C Correlates with the Progression of Liver Fibrosis in Chronic Hepatitis C Patients
Drug Metab. Dispos., September 1, 2008; 36(9): 1786 - 1793.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.